Multidimensional Flow Cytometry for Detection of Rare Populations in Hematological Malignancies

Chi Cheng Li, Michael R. Loken, Ruey Ho Kao, Tso Fu Wang, Shii Shou Tsai, Shu Min Hsu, Chao Yuan Yao, Szu Chin Li, Kuan Po Huang, Yi Feng Wu, Wei Han Huang, Sung Chao Chu

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: Flow cytometry is becoming an important tool in the characterization of different hematological disorders. The aim of our study was to detect very rare populations in hematological malignancies using the comprehensive concept of immunophenotyping. Patients and Methods: Six patients, including three with acute myeloid leukemia, one with acute lymphoblastic leukemia, one with myelodysplastic syndrome, and one with B-cell lymphoma, were enrolled in this study. Serial bone marrow aspirates were analyzed by three-color multidimensional flow cytometry. Results: The core principles for the use of flow cytometric analysis are understanding deviations in abnormal antigen expression from normal cellular differentiating pathways and characterizing different patterns of antigenic aberrancy for each patient. Our results demonstrate that multidimensional flow cytometry can be used to: (1) monitor minimal residual disease after treatment; (2) aid in the differential diagnosis of cases, which are difficult to evaluate using conventional morphology; and (3) help in the staging of lymphoproliferative disorders. Conclusion: After selecting appropriate combinations of monoclonal antibodies, and applying advanced knowledge in immunophenotyping, flow cytometry is very sensitive and specific for the detection of rare populations in hematological disorders.

Original languageEnglish
Pages (from-to)40-51
Number of pages12
JournalTzu Chi Medical Journal
Volume21
Issue number1
DOIs
Publication statusPublished - Mar 1 2009
Externally publishedYes

Fingerprint

Hematologic Neoplasms
Flow Cytometry
Immunophenotyping
Population
Lymphoproliferative Disorders
Myelodysplastic Syndromes
Residual Neoplasm
B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acute Myeloid Leukemia
Differential Diagnosis
Color
Bone Marrow
Monoclonal Antibodies
Antigens
Therapeutics

Keywords

  • Flow cytometry
  • Leukemia
  • Lymphoproliferative disorder
  • Minimal residual disease
  • Myelodysplastic syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Multidimensional Flow Cytometry for Detection of Rare Populations in Hematological Malignancies. / Li, Chi Cheng; Loken, Michael R.; Kao, Ruey Ho; Wang, Tso Fu; Tsai, Shii Shou; Hsu, Shu Min; Yao, Chao Yuan; Li, Szu Chin; Huang, Kuan Po; Wu, Yi Feng; Huang, Wei Han; Chu, Sung Chao.

In: Tzu Chi Medical Journal, Vol. 21, No. 1, 01.03.2009, p. 40-51.

Research output: Contribution to journalArticle

Li, CC, Loken, MR, Kao, RH, Wang, TF, Tsai, SS, Hsu, SM, Yao, CY, Li, SC, Huang, KP, Wu, YF, Huang, WH & Chu, SC 2009, 'Multidimensional Flow Cytometry for Detection of Rare Populations in Hematological Malignancies', Tzu Chi Medical Journal, vol. 21, no. 1, pp. 40-51. https://doi.org/10.1016/S1016-3190(09)60007-0
Li, Chi Cheng ; Loken, Michael R. ; Kao, Ruey Ho ; Wang, Tso Fu ; Tsai, Shii Shou ; Hsu, Shu Min ; Yao, Chao Yuan ; Li, Szu Chin ; Huang, Kuan Po ; Wu, Yi Feng ; Huang, Wei Han ; Chu, Sung Chao. / Multidimensional Flow Cytometry for Detection of Rare Populations in Hematological Malignancies. In: Tzu Chi Medical Journal. 2009 ; Vol. 21, No. 1. pp. 40-51.
@article{48f511b202f84f88aa9464dbc2423db9,
title = "Multidimensional Flow Cytometry for Detection of Rare Populations in Hematological Malignancies",
abstract = "Objective: Flow cytometry is becoming an important tool in the characterization of different hematological disorders. The aim of our study was to detect very rare populations in hematological malignancies using the comprehensive concept of immunophenotyping. Patients and Methods: Six patients, including three with acute myeloid leukemia, one with acute lymphoblastic leukemia, one with myelodysplastic syndrome, and one with B-cell lymphoma, were enrolled in this study. Serial bone marrow aspirates were analyzed by three-color multidimensional flow cytometry. Results: The core principles for the use of flow cytometric analysis are understanding deviations in abnormal antigen expression from normal cellular differentiating pathways and characterizing different patterns of antigenic aberrancy for each patient. Our results demonstrate that multidimensional flow cytometry can be used to: (1) monitor minimal residual disease after treatment; (2) aid in the differential diagnosis of cases, which are difficult to evaluate using conventional morphology; and (3) help in the staging of lymphoproliferative disorders. Conclusion: After selecting appropriate combinations of monoclonal antibodies, and applying advanced knowledge in immunophenotyping, flow cytometry is very sensitive and specific for the detection of rare populations in hematological disorders.",
keywords = "Flow cytometry, Leukemia, Lymphoproliferative disorder, Minimal residual disease, Myelodysplastic syndrome",
author = "Li, {Chi Cheng} and Loken, {Michael R.} and Kao, {Ruey Ho} and Wang, {Tso Fu} and Tsai, {Shii Shou} and Hsu, {Shu Min} and Yao, {Chao Yuan} and Li, {Szu Chin} and Huang, {Kuan Po} and Wu, {Yi Feng} and Huang, {Wei Han} and Chu, {Sung Chao}",
year = "2009",
month = "3",
day = "1",
doi = "10.1016/S1016-3190(09)60007-0",
language = "English",
volume = "21",
pages = "40--51",
journal = "Tzu Chi Medical Journal",
issn = "1016-3190",
publisher = "財團法人中華民國佛教慈濟慈善事業基金會",
number = "1",

}

TY - JOUR

T1 - Multidimensional Flow Cytometry for Detection of Rare Populations in Hematological Malignancies

AU - Li, Chi Cheng

AU - Loken, Michael R.

AU - Kao, Ruey Ho

AU - Wang, Tso Fu

AU - Tsai, Shii Shou

AU - Hsu, Shu Min

AU - Yao, Chao Yuan

AU - Li, Szu Chin

AU - Huang, Kuan Po

AU - Wu, Yi Feng

AU - Huang, Wei Han

AU - Chu, Sung Chao

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Objective: Flow cytometry is becoming an important tool in the characterization of different hematological disorders. The aim of our study was to detect very rare populations in hematological malignancies using the comprehensive concept of immunophenotyping. Patients and Methods: Six patients, including three with acute myeloid leukemia, one with acute lymphoblastic leukemia, one with myelodysplastic syndrome, and one with B-cell lymphoma, were enrolled in this study. Serial bone marrow aspirates were analyzed by three-color multidimensional flow cytometry. Results: The core principles for the use of flow cytometric analysis are understanding deviations in abnormal antigen expression from normal cellular differentiating pathways and characterizing different patterns of antigenic aberrancy for each patient. Our results demonstrate that multidimensional flow cytometry can be used to: (1) monitor minimal residual disease after treatment; (2) aid in the differential diagnosis of cases, which are difficult to evaluate using conventional morphology; and (3) help in the staging of lymphoproliferative disorders. Conclusion: After selecting appropriate combinations of monoclonal antibodies, and applying advanced knowledge in immunophenotyping, flow cytometry is very sensitive and specific for the detection of rare populations in hematological disorders.

AB - Objective: Flow cytometry is becoming an important tool in the characterization of different hematological disorders. The aim of our study was to detect very rare populations in hematological malignancies using the comprehensive concept of immunophenotyping. Patients and Methods: Six patients, including three with acute myeloid leukemia, one with acute lymphoblastic leukemia, one with myelodysplastic syndrome, and one with B-cell lymphoma, were enrolled in this study. Serial bone marrow aspirates were analyzed by three-color multidimensional flow cytometry. Results: The core principles for the use of flow cytometric analysis are understanding deviations in abnormal antigen expression from normal cellular differentiating pathways and characterizing different patterns of antigenic aberrancy for each patient. Our results demonstrate that multidimensional flow cytometry can be used to: (1) monitor minimal residual disease after treatment; (2) aid in the differential diagnosis of cases, which are difficult to evaluate using conventional morphology; and (3) help in the staging of lymphoproliferative disorders. Conclusion: After selecting appropriate combinations of monoclonal antibodies, and applying advanced knowledge in immunophenotyping, flow cytometry is very sensitive and specific for the detection of rare populations in hematological disorders.

KW - Flow cytometry

KW - Leukemia

KW - Lymphoproliferative disorder

KW - Minimal residual disease

KW - Myelodysplastic syndrome

UR - http://www.scopus.com/inward/record.url?scp=65549159909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549159909&partnerID=8YFLogxK

U2 - 10.1016/S1016-3190(09)60007-0

DO - 10.1016/S1016-3190(09)60007-0

M3 - Article

AN - SCOPUS:65549159909

VL - 21

SP - 40

EP - 51

JO - Tzu Chi Medical Journal

JF - Tzu Chi Medical Journal

SN - 1016-3190

IS - 1

ER -